摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-(4-chlorobenzyl)-N'-ethylthiourea | 57294-95-8

中文名称
——
中文别名
——
英文名称
N-(4-chlorobenzyl)-N'-ethylthiourea
英文别名
1-(4-Chlorobenzyl)-3-ethylthiourea;1-[(4-chlorophenyl)methyl]-3-ethylthiourea
N-(4-chlorobenzyl)-N'-ethylthiourea化学式
CAS
57294-95-8
化学式
C10H13ClN2S
mdl
MFCD04208855
分子量
228.746
InChiKey
UWZZUKMOHNJNEX-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.5
  • 重原子数:
    14
  • 可旋转键数:
    3
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.3
  • 拓扑面积:
    56.2
  • 氢给体数:
    2
  • 氢受体数:
    1

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    N-(4-chlorobenzyl)-N'-ethylthiourea4-(3-bromopropyl)-1H-imidazole hydrobromide乙醇 为溶剂, 反应 48.0h, 以25%的产率得到N-(4-chlorobenzyl)-N'-ethyl-S-[3-(4(5)-imidazolyl)propyl]isothiourea dihydrobromide
    参考文献:
    名称:
    Development of a Pharmacophore Model for Histamine H3 Receptor Antagonists, Using the Newly Developed Molecular Modeling Program SLATE
    摘要:
    New molecular modeling tools were developed to construct a qualitative pharmacophore model for histamine HQ receptor antagonists. The program SLATE superposes ligands assuming optimum hydrogen bond geometry. One or two ligands are allowed to flex in the procedure, thereby enabling the determination of the bioactive conformation of flexible Hg antagonists. In the derived model, four hydrogen-bonding site points and two hydrophobic pockets available for binding antagonists are revealed. The model results in a better understanding of the structure-activity relationships of Ha antagonists. To validate the model, a series of new antagonists was synthesized. The compounds were designed to interact with all four hydrogen-bonding site points and the two hydrophobic pockets simultaneously. These ligands have high HE receptor affinity, thereby illustrating how the model can be used in the design of new classes of H-3 antagonists.
    DOI:
    10.1021/jm001109k
  • 作为产物:
    描述:
    异硫氰酸乙酯对氯苄胺乙醚 为溶剂, 反应 2.0h, 以90%的产率得到N-(4-chlorobenzyl)-N'-ethylthiourea
    参考文献:
    名称:
    Development of a Pharmacophore Model for Histamine H3 Receptor Antagonists, Using the Newly Developed Molecular Modeling Program SLATE
    摘要:
    New molecular modeling tools were developed to construct a qualitative pharmacophore model for histamine HQ receptor antagonists. The program SLATE superposes ligands assuming optimum hydrogen bond geometry. One or two ligands are allowed to flex in the procedure, thereby enabling the determination of the bioactive conformation of flexible Hg antagonists. In the derived model, four hydrogen-bonding site points and two hydrophobic pockets available for binding antagonists are revealed. The model results in a better understanding of the structure-activity relationships of Ha antagonists. To validate the model, a series of new antagonists was synthesized. The compounds were designed to interact with all four hydrogen-bonding site points and the two hydrophobic pockets simultaneously. These ligands have high HE receptor affinity, thereby illustrating how the model can be used in the design of new classes of H-3 antagonists.
    DOI:
    10.1021/jm001109k
点击查看最新优质反应信息

文献信息

  • Aminolysis of Aryl <i>N</i>-Ethyl Thionocarbamates: Cooperative Effects of Atom Pairs O and S on the Reactivity and Mechanism
    作者:Hyuck Keun Oh、Ji Young Oh、Dae Dong Sung、Ikchoon Lee
    DOI:10.1021/jo050606b
    日期:2005.7.1
    with benzylamines (XC6H4CH2NH2) in acetonitrile are investigated at 30.0 °C. The rate of ETNC is slower by a factor of ca. 3 than the corresponding aminolysis of aryl N-ethyl thiocarbamate (AETC/EtHN-(CO)-SC6H4Z), which has been interpreted in terms of cooperative effects of atom pairs O and S on the reactivity and mechanism. For concerted processes, these effects predict a rate sequence, −C(S)−S− <
    在30.0°C下研究了芳基N-乙基硫代氨基甲酸酯(ETNC / EtHN-C(S)-OC 6 H 4 Z)与苄胺(XC 6 H 4 CH 2 NH 2)的氨解反应。ETNC的速度减慢了大约两倍。与芳基N-乙基硫代氨基甲酸酯的相应氨解反应(AETC / EtHN-(C O)-SC 6 H 4 Z)相比,它的原子分解反应要比图3所示,这是根据原子对O和S对反应性和机理的协同作用来解释的。对于一致的过程,这些效应可预测速率序列-C(S)-S- <-C(S)-O- <-C-(O)-S- <-C-(O)-O-,并且当前结果与此顺序一致。负交叉相互作用常数,ρ XZ = -0.87,的幅度β Ž(= 0.36-0.50)和失败的RSP的是在与该协同机制一致。涉及氘化苄胺的正常动力学同位素效应k H / k D = 1.52-1.78表明存在氢键合的环状过渡态。还讨论了影响该机制的其他因素。
  • VASSILEV G. N.; YONOVA P. A., DOKL. BOLG. AN. <DVAN-AD>, 1975, 28, NO 7, 931-933
    作者:VASSILEV G. N.、 YONOVA P. A.
    DOI:——
    日期:——
  • Development of a Pharmacophore Model for Histamine H<sub>3</sub> Receptor Antagonists, Using the Newly Developed Molecular Modeling Program SLATE
    作者:Iwan J. P. De Esch、James E. J. Mills、Tim D. J. Perkins、Giuseppe Romeo、Marcel Hoffmann、Kerstin Wieland、Rob Leurs、Wiro M. P. B. Menge、Paul H. J. Nederkoorn、Philip M. Dean、Henk Timmerman
    DOI:10.1021/jm001109k
    日期:2001.5.1
    New molecular modeling tools were developed to construct a qualitative pharmacophore model for histamine HQ receptor antagonists. The program SLATE superposes ligands assuming optimum hydrogen bond geometry. One or two ligands are allowed to flex in the procedure, thereby enabling the determination of the bioactive conformation of flexible Hg antagonists. In the derived model, four hydrogen-bonding site points and two hydrophobic pockets available for binding antagonists are revealed. The model results in a better understanding of the structure-activity relationships of Ha antagonists. To validate the model, a series of new antagonists was synthesized. The compounds were designed to interact with all four hydrogen-bonding site points and the two hydrophobic pockets simultaneously. These ligands have high HE receptor affinity, thereby illustrating how the model can be used in the design of new classes of H-3 antagonists.
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐